BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28269752)

  • 21. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
    Foteinou E; Kontos CK; Giotakis AI; Scorilas A
    Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.
    Dong J; Xu M
    Oncol Rep; 2019 Jun; 41(6):3233-3243. PubMed ID: 31002358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiles reveal key genes for early diagnosis and treatment of adamantinomatous craniopharyngioma.
    Yang J; Hou Z; Wang C; Wang H; Zhang H
    Cancer Gene Ther; 2018 Oct; 25(9-10):227-239. PubMed ID: 29681617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD44 expression predicts local recurrence after radiotherapy in larynx cancer.
    de Jong MC; Pramana J; van der Wal JE; Lacko M; Peutz-Kootstra CJ; de Jong JM; Takes RP; Kaanders JH; van der Laan BF; Wachters J; Jansen JC; Rasch CR; van Velthuysen ML; Grénman R; Hoebers FJ; Schuuring E; van den Brekel MW; Begg AC
    Clin Cancer Res; 2010 Nov; 16(21):5329-38. PubMed ID: 20837694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
    de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
    Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A random forest classifier predicts recurrence risk in patients with ovarian cancer.
    Cheng L; Li L; Wang L; Li X; Xing H; Zhou J
    Mol Med Rep; 2018 Sep; 18(3):3289-3297. PubMed ID: 30066910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid Method Based on Information Gain and Support Vector Machine for Gene Selection in Cancer Classification.
    Gao L; Ye M; Lu X; Huang D
    Genomics Proteomics Bioinformatics; 2017 Dec; 15(6):389-395. PubMed ID: 29246519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A six‑gene support vector machine classifier contributes to the diagnosis of pediatric septic shock.
    Long G; Yang C
    Mol Med Rep; 2020 Mar; 21(3):1561-1571. PubMed ID: 32016447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Learning to predict relapse in invasive ductal carcinomas based on the subcellular localization of junctional proteins.
    Asgarian N; Hu X; Aktary Z; Chapman KA; Lam L; Chibbar R; Mackey J; Greiner R; Pasdar M
    Breast Cancer Res Treat; 2010 Jun; 121(2):527-38. PubMed ID: 19787450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of grade-related genes and construction of a robust genomic-clinicopathologic nomogram for predicting recurrence of bladder cancer.
    Peng X; Wang J; Li D; Chen X; Liu K; Zhang C; Lai Y
    Medicine (Baltimore); 2020 Nov; 99(47):e23179. PubMed ID: 33217824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
    Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
    Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression and function of epithelial membrane protein 1 in laryngeal carcinoma.
    Li H; Zhang X; Jiang X; Ji X
    Int J Oncol; 2017 Jan; 50(1):141-148. PubMed ID: 27909719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable Gene Signature Selection for Prediction of Breast Cancer Recurrence Using Joint Mutual Information.
    Sehhati M; Mehridehnavi A; Rabbani H; Pourhossein M
    IEEE/ACM Trans Comput Biol Bioinform; 2015; 12(6):1440-8. PubMed ID: 26671813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of prognostic immune genes in laryngeal cancer.
    Xiao H; Su QS; Li CQ
    J Int Med Res; 2020 Nov; 48(11):300060520964662. PubMed ID: 33147419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prognostic multigene classifier for squamous cell carcinomas of the larynx.
    Mirisola V; Mora R; Esposito AI; Guastini L; Tabacchiera F; Paleari L; Amaro A; Angelini G; Dellepiane M; Pfeffer U; Salami A
    Cancer Lett; 2011 Aug; 307(1):37-46. PubMed ID: 21481529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying potential drug targets in hepatocellular carcinoma based on network analysis and one-class support vector machine.
    Tong Z; Zhou Y; Wang J
    Sci Rep; 2019 Jul; 9(1):10442. PubMed ID: 31320657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly informative marker sets consisting of genes with low individual degree of differential expression.
    Galatenko VV; Shkurnikov MY; Samatov TR; Galatenko AV; Mityakina IA; Kaprin AD; Schumacher U; Tonevitsky AG
    Sci Rep; 2015 Oct; 5():14967. PubMed ID: 26446398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.